A network of governance committees and interest groups plays a vital role in informing our work under the National Immunoglobulin Governance Program.

The NBA's principal Ig governance committee is the National Immunoglobulin Governance Advisory Committee (NIGAC). The NIGAC and 4 immunoglobulin specialist working groups (SWGs) provide expert guidance to ensure our criteria reflect current scientific evidence. They also provide advice on other Ig governance-related issues, including:

  • education
  • governance framework
  • performance improvements
  • research.

Our Jurisdictional Immunoglobulin Performance Improvement (JIPI) Group provides a forum for the NBA and jurisdictions (states and territories) to share information and coordinate and discuss immunoglobulin governance-related activities and initiatives. This complements the work of the jurisdictions’ own immunoglobulin interest groups, known as the Jurisdictional Immunoglobulin Interest Groups, or JIIGs.

We also have an informal National Immunoglobulin Interest Group (NIIG). We invite anyone involved in any aspect of Ig use and management, from medical professionals to patients and carers, to join this group if they would like to keep abreast of, and potentially contribute to, discussions on relevant topics. Occasionally, we may contact NIIG members and invite them to participate in activities.

Learn more about how we manage immunoglobulin products.

For recent activities of Ig governance committees and groups, see our latest updates.

National Immunoglobulin Governance Advisory Committee

Our peak Ig governance committee is the National Immunoglobulin Governance Advisory Committee (NIGAC). The NIGAC is a statutory committee established under section 38 of the National Blood Authority Act 2003 (Cth)(Opens in a new tab/window).

The NIGAC meets up to 3 times a year. The committee provides advice and makes recommendations about our Ig governance program.

The committee helps to ensure access to government-funded Ig is fair and equitable. It also aims to evolve and improve Australia's Ig governance and management.

Membership

NIGAC members are leaders who act as champions for our Ig governance program.

Our Chief Executive appoints members based on their experience and expertise and renews memberships through a rolling review process. Appointments are initially for 3 years, with a maximum term of 8 years.

NIGAC members represent key stakeholders from different clinical disciplines, organisations and jurisdictions.

Become a NIGAC member

When required, we seek formal expressions of interest for NIGAC membership approximately every 3 years.

Current members

Each medical specialist member also chairs their relevant Specialist Working Group.

Chair

Professor Robert Moulds, Medical Advisor, Therapeutic Guidelines Ltd; Emeritus Professor of Medicine, Fiji National University.

Medical specialist – haematology

Professor Dipti Talaulikar, Clinical haematologist, Canberra Health Services, School of Medicine and Psychology, College of Health and Medicine, Australian National University

Medical specialist – immunology

Dr Melanie Wong, Senior Staff Specialist Immunologist and Immunopathologist, Director of Immunology Laboratory; Head, Immunodeficiency Service, Department of Allergy and Immunology, The Children’s Hospital at Westmead, NSW.

Medical specialist – neurology

Associate Professor Stephen Reddel, Staff Specialist Neurologist, Concord Repatriation General Hospital, NSW.

Medical specialist – transplant medicine

Dr Kovi Levin, Respiratory and Lung Transplant Physician, The Alfred, Vic.

Consumer representatives (2)

Mr Adam Friederich, National Patient Advisory Panel Chair, Immune Deficiencies Foundation Australia.

Position vacant.

Dispenser representative

Ms Annette Le Viellez, Senior Scientist in Charge Transfusion Medicine, PathWest South-East Division, WA.

Epidemiologist

Dr Surendra Karki, Research Fellow/Epidemiologist, Research and Development, Australian Red Cross Lifeblood; Adjunct Lecturer, School of Population Health, University of New South Wales, NSW.

Health economist

Associate Professor Silva Zavarsek, Health Technology Assessment, Deakin Health Economics, Institute for Health Transformation‚ÄØ, School of Health and Social Development, Faculty of Health.

Nurse representatives (2)

Ms Rachael Dunn, Clinical Nurse Specialist Immunology, Perth Children’s Hospital, WA.

Position vacant.

Commonwealth representative

Dr Neil Everest, Senior Medical Adviser, Technology Assessment and Access Division, Department of Health and Aged Care.

Large jurisdiction representative

Helen Seeto, Principal Policy Adviser– Specialty Programs, Commissioning and Systems Improvement Division, Department of Health, Vic

Small jurisdiction representative

Ms Carolyn Duck, ACT Blood Counts Program Manager, Blood and Blood Products, Canberra Health Services, ACT.

NBA representatives (2)

Mr John Cahill, Chief Executive, National Blood Authority.

Mr Ben Noyen, Deputy Chief Executive, National Blood Authority.

Observer

Dr Joanne Pink, Executive Director, Pathology and Clinical Governance, and Chief Medical Officer, Australian Red Cross Lifeblood.

Immunoglobulin Specialist Working Groups

Our Immunoglobulin Specialist Working Groups (SWGs) provide expert advice in:

  • haematology
  • immunology
  • neurology
  • transplant medicine.

There's an SWG for each of these 4 specialisations. The chair of each SWG sits on the NIGAC to represent the views of their group.

We seek input from other specialist areas, such as rheumatology or dermatology, on an as-needed basis.

SWGs usually meet remotely 2 to 3 times per year. They may hold extra meetings for urgent single-issue advice.

Among other things, our SWGs:

  • give specialist feedback and clinical advice
  • make recommendations on our criteria for access to Ig
  • provide advice on contingency planning
  • provide insight and advice to guide continuous improvement activities.

The SWGs work with each other and the network of national and jurisdictional committees to inform our Ig governance program.

Membership

SWG members are leaders who act as champions for our Ig governance program.

Our Chief Executive appoints members based on their experience and expertise. Appointments are for 3 years, with the possibility of reappointment.

Become an SWG member

When required, we seek formal expressions of interest for SWG membership approximately every 3 years.

Current members

Haematology SWG

Chair

Professor Dipti Talaulikar, Clinical haematologist, Canberra Health Services, School of Medicine and Psychology, College of Health and Medicine, Australian National University

Members

Dr Philip Choi, Senior Staff Specialist Haematologist, Principal Investigator, Senior Lecturer (Hon), National Platelet Research and Referral Centre, The John Curtin School of Medical Research, Australian National University

Professor John Gibson AM, Consultant Emeritus Haematologist, Royal Prince Alfred Hospital, NSW.

Dr Anna Johnston, Director, Clinical Haematology and Statewide Bone Marrow Transplant Service, Royal Hobart Hospital, Tas.

Dr Meg Wall, Genetic Pathologist, Victorian Clinical Genetics Services (VCGS), Murdoch Children’s Research Institute, Vic.

Observer

Dr Lydia Singaraveloo, Transfusion Medicine Specialist, Pathology and Clinical Governance, Australian Red Cross Lifeblood.

Immunology SWG

Chair

Dr Melanie Wong, Senior Staff Specialist Immunologist and Immunopathologist, Director of Immunology Laboratory; Head, Immunodeficiency Service, Department of Allergy and Immunology, The Children’s Hospital at Westmead, NSW.

Members

Dr Theresa Cole, Paediatric Allergist Immunologist, The Royal Children’s Hospital, Vic.

Dr Alisa Kane, Staff Specialist Clinical Immunologist, St Vincent's Hospital and Liverpool Hospital, NSW.

Dr Daman Langguth, Clinical Immunologist, Director of Immunology at Sullivan Nicolaides Pathology, The Wesley Hospital Campus, Qld.

Observer

Dr Lydia Singaraveloo, Transfusion Medicine Specialist, Pathology and Clinical Governance, Australian Red Cross Lifeblood.

Neurology SWG

Chair

Associate Professor Stephen Reddel, Staff Specialist Neurologist, Concord Repatriation General Hospital, NSW.

Members

Dr Nicholas Crump, Neurologist and Neurophysiologist, Austin Health, Vic.

Prof Russell Dale, Professor of Paediatric Neurology, The Children's Hospital at Westmead; Faculty of Medicine and Health, University of Sydney, NSW.

Professor Christian Gericke, Clinical Director of Neurology, The Prince Charles Hospital, Brisbane; Professor of Medicine, University of Queensland, Qld.

Dr Judith Spies, Senior Staff Specialist, Neurology, Royal Prince Alfred Hospital, NSW.

Prof Bruce Taylor, Academic Lead MS Flagship Research Program and Professorial Research Fellow, Menzies Institute for Medical Research, University of Tasmania; Consultant Neurologist, Royal Hobart Hospital, Tas.

Observer

Dr Lydia Singaraveloo, Transfusion Medicine Specialist, Pathology and Clinical Governance, Australian Red Cross Lifeblood.

Transplant medicine SWG

Chair

Dr Kovi Levin, Respiratory and Lung Transplant Physician, The Alfred, Vic.

Members

Dr Joshua Kausman, Director of Nephrology and Staff Paediatric Nephrologist, Department of Nephrology, The Royal Children’s Hospital, Vic.

Prof Peter Macdonald, Staff Specialist, Heart and Lung Transplant Unit, St Vincent’s Hospital, NSW.

Assoc Prof William Mulley, Nephrologist and Transplant Physician, Department of Nephrology, Monash Medical Centre, Vic.

Observer

Dr Lydia Singaraveloo, Transfusion Medicine Specialist, Pathology and Clinical Governance, Australian Red Cross Lifeblood.

Jurisdictional Immunoglobulin Performance Improvement Group

The Jurisdictional Immunoglobulin Performance Improvement (JIPI) Group is an informal group formed in 2020. The JIPI Group supports a collaborative approach to implementing the National Immunoglobulin Governance Program Performance Improvement Strategy 2019–20 to 2021–22.

The JIPI Group provides a forum for the people who implement Ig governance arrangements to share ideas and activities to enhance:

  • analysis
  • benchmarking
  • compliance
  • data collection
  • governance activities
  • reporting.

The JIPI Group meets remotely as needed. Members often communicate between meetings to continue their work as a forum for sharing ideas.

Membership

JIPI Group members are representatives from each of the Australian, state and territory governments and the National Blood Authority (NBA).

Members must have a strong interest in Ig governance and a broad knowledge of health care. They must also be able to represent their jurisdiction to support program improvement activities.

Become a JIPI Group member

JIPI Group membership is by invitation only.

National Immunoglobulin Interest Group

The National Immunoglobulin Interest Group (NIIG) is an informal group for anyone interested in Ig use or management.

Members of the NIIG receive our National Ig Governance Program updates. We may also invite them to comment on Ig issues such as:

  • BloodSTAR functionality and usability
  • educational material and resources
  • governance policy
  • governance program implementation and improvement.

Membership

Membership to the NIIG is open to anyone interested in Ig use or management.

Members could include:

  • administrators
  • carers
  • medical professionals
  • patients
  • policymakers
  • other interested parties.

Become an NIIG member

To join the NIIG, email us at IgGovernance@blood.gov.au.

You may also like to subscribe to receive regular Ig program updates.

Subscribe to Ig program updates

To subscribe for updates, email us at IgGovernance@blood.gov.au and include the following in your email:

  • in the subject line, put 'SUBSCRIBE Ig Program Updates'
  • in the body of the email, let us know whether you're a healthcare professional, patient or other Ig stakeholder
  • in the body of the email, add your contact details or signature block.

Other interest groups

There are other interest groups and forums outside the National Blood Authority where you can get involved. This includes patient support groups and jurisdictional Ig interest groups.

To find out how to get in touch with a patient support group, please contact us.

Jurisdictional Immunoglobulin Interest Groups

State and territory health departments create their Jurisdictional Immunoglobulin Interest Groups (JIIGs).

While they don’t sit under the NBA, they’re an integral part of the network responsible for Australia’s Ig governance and management.

JIIGs foster communication between policymakers and the people who implement Ig governance in jurisdictions.

Among other things, JIIGs can help us:

  • identify, communicate and resolve Ig policy and criteria issues
  • develop and implement program improvements.

Membership

JIIG members differ across jurisdictions, but they're usually people who have an interest in Ig use and governance.

Members might be:

  • medical specialists in haematology, immunology, neurology or transplant medicine
  • medical scientists
  • nurses
  • patients
  • representatives from Australian Red Cross Lifeblood
  • other people a jurisdiction selects.

Become a JIIG member

Each jurisdiction selects its JIIG members. Contact your state or territory's health department to register your interest.

Get in touch

For more information about our committees, including membership, contact us.

Phone: 1300 025 663 (13 000 BLOOD)

Email: IgGovernance@blood.gov.au

Last updated: 27 Mar 2024

Back to top